Cancer Management and Research
Volume 13, 2021 - Issue
Open access
88
Views
3
CrossRef citations to date
0
Altmetric
Original Research
LNC00115 Mediates Cisplatin Resistance by Regulating the miR-7/ERK Signalling Pathway in Ovarian Cancer
Xinyan JiangThe First Affiliated Hospital, Harbin Medical University, Harbin, People’s Republic of China
, Yan ChengThe First Affiliated Hospital, Harbin Medical University, Harbin, People’s Republic of China
, Yanan HeThe First Affiliated Hospital, Harbin Medical University, Harbin, People’s Republic of China
, Shanshan CongThe First Affiliated Hospital, Harbin Medical University, Harbin, People’s Republic of China
, Liyuan SunThe First Affiliated Hospital, Harbin Medical University, Harbin, People’s Republic of China
, Di WuThe First Affiliated Hospital, Harbin Medical University, Harbin, People’s Republic of China
, Han WuThe First Affiliated Hospital, Harbin Medical University, Harbin, People’s Republic of China
https://orcid.org/0000-0002-8996-2024
Guangmei ZhangThe First Affiliated Hospital, Harbin Medical University, Harbin, People’s Republic of ChinaCorrespondence[email protected]
show all
Pages 3817-3826
|
Published online: 11 May 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.